Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/24/1998 | US5840304 Amino acid sequences and codes for t-cells |
11/24/1998 | US5840302 Treatment of bacterially-induced inflammatory diseases |
11/24/1998 | US5840301 Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors |
11/24/1998 | US5840300 Methods and compositions comprising single chain recombinant antibodies |
11/24/1998 | US5840299 Binding and treatment of multiple sclerosis |
11/24/1998 | US5840298 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
11/24/1998 | US5840297 Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process |
11/24/1998 | US5840083 A medical equipment for grafting in mammalian body comprising an amphiphilic coatings having an antibodies receptor molecule conjugated to a supports lipids and membrane protein; ion conductivity |
11/24/1998 | CA2088579C Agents that bind to vcam-1 and uses thereof |
11/24/1998 | CA1340140C Human gamma, delta t cell antigen receptor polypetides and nucleic acids |
11/24/1998 | CA1340139C Particle-stabilized epitopes for standardization and control of immunoassays |
11/23/1998 | CA2232810A1 Novel compounds |
11/23/1998 | CA2232809A1 Novel compounds |
11/23/1998 | CA2232807A1 Novel compounds |
11/23/1998 | CA2230996A1 Novel compounds |
11/23/1998 | CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639) |
11/23/1998 | CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1 |
11/22/1998 | CA2231017A1 A member of the frzb family, frazzled |
11/22/1998 | CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9 |
11/21/1998 | CA2232811A1 Novel def1 |
11/19/1998 | WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
11/19/1998 | WO1998051824A1 Reagents and methods useful for detecting disease of the urinary tract |
11/19/1998 | WO1998051801A1 Gene encoding for systemic acquired resistance in arabidopsis |
11/19/1998 | WO1998051796A1 Polynucleotides encoding a cd53-like transmembrane protein |
11/19/1998 | WO1998051794A1 Antimicrobial peptide |
11/19/1998 | WO1998051793A1 Apo-2 RECEPTOR |
11/19/1998 | WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
11/19/1998 | WO1998051708A1 A method for the improvement of neuronal regeneration |
11/19/1998 | WO1998051706A1 Tumor-associated antigen |
11/19/1998 | WO1998051701A1 Tumor surface protein and its complementary surface receptor on naive natural killer cells |
11/19/1998 | WO1998051350A1 Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies |
11/19/1998 | WO1998051346A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies |
11/19/1998 | WO1998051345A2 Method for dislodging infiltrated leukocytes from a tissue |
11/19/1998 | WO1998051344A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
11/19/1998 | WO1998051343A1 Use of an anti-lfa1 monoclonal antibody in kidney transplantation |
11/19/1998 | WO1998051337A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
11/19/1998 | WO1998051335A1 Methods of modulating immune coagulation |
11/19/1998 | WO1998051330A1 Method and compositions for treating hyperlipidemia and other conditions |
11/19/1998 | WO1998051329A1 Cachexia remedy |
11/19/1998 | WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
11/19/1998 | WO1998051321A1 Tissue factor for influencing blood vessel formation |
11/19/1998 | WO1998040483A3 28 human secreted proteins |
11/19/1998 | WO1998035694A3 A pharmaceutical composition for treating hepatitis b virus (hbv) infection |
11/19/1998 | WO1998035061A3 Member of the tnf family useful for treatment and diagnosis of disease |
11/19/1998 | DE19726597C1 Preparation of human monoclonal antibodies |
11/19/1998 | DE19721700C1 Mutierter OKT3-Antikörper Mutated OKT3 antibody |
11/19/1998 | CA2290781A1 Antimicrobial peptide |
11/19/1998 | CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
11/19/1998 | CA2290477A1 Polynucleotides encoding a cd53-like transmembrane protein |
11/19/1998 | CA2290071A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
11/19/1998 | CA2290067A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies |
11/19/1998 | CA2290021A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
11/19/1998 | CA2289910A1 Therapeutic agent for cachexia |
11/19/1998 | CA2289751A1 Gene encoding for systemic acquired resistance in arabidopsis |
11/19/1998 | CA2288599A1 Tumor-associated antigen |
11/19/1998 | CA2288117A1 Tissue factor for influencing blood vessel formation |
11/19/1998 | CA2287911A1 Apo-2 receptor |
11/19/1998 | CA2286875A1 Chemical compounds |
11/19/1998 | CA2221866A1 A novel member of the il-1 family, il-1 delta |
11/18/1998 | EP0878545A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines |
11/18/1998 | EP0878544A1 Epididymis specific DNA sequences and their use |
11/18/1998 | EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor |
11/18/1998 | EP0878480A1 A method for the improvement of neuronal regeneration |
11/18/1998 | EP0878479A2 G-protein coupled receptor (HOFNH30) |
11/18/1998 | EP0877943A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
11/18/1998 | EP0877819A1 Disruption of expression of multiple alleles of mammalian genes |
11/18/1998 | EP0877812A1 Antibodies and immunoglobulin fusion proteins having modified effector functions and uses therefor |
11/18/1998 | EP0877809A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
11/18/1998 | EP0877808A1 Decorin binding protein compositions and methods of use |
11/18/1998 | EP0877806A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof |
11/18/1998 | EP0877802A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
11/18/1998 | EP0877798A1 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer |
11/18/1998 | EP0877795A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
11/18/1998 | EP0877758A2 PURIFIED SR-p70 PROTEIN |
11/18/1998 | EP0877757A1 Method for evaluating and affecting male fertility |
11/18/1998 | EP0877755A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
11/18/1998 | EP0877626A2 Anti-cd18 antibodies for use against stroke |
11/18/1998 | EP0877622A1 Method of inactivation of ras subfamily proteins and agents therefor |
11/18/1998 | EP0686261A4 Detection of type ii collagen and its peptides |
11/18/1998 | EP0551501B1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
11/18/1998 | EP0550519B1 Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
11/18/1998 | CN1199422A Transgenic non-human animals capable of producing heterologous antibodies |
11/18/1998 | CN1198951A Immunoglobulin preparation and preparation process thereof |
11/17/1998 | US5837846 Biosynthetic binding proteins for immuno-targeting |
11/17/1998 | US5837845 Dna encoded human monoclonal antibodies for binding antigens of stomach cancer cells |
11/17/1998 | US5837842 Vascular anticoagulant proteins DNA which codes them, processer for preparing them and their use |
11/17/1998 | US5837824 Binds to monoclonal antibody bw 835, dsm acc 2022; use of epitope for diagnosis and therapy |
11/17/1998 | US5837823 Antibodies to adrenomedullin |
11/17/1998 | US5837822 Intercellular adhesion molecule polypeptide; genetic engineering; gene expression; antiinflammatory agents |
11/17/1998 | US5837821 Antibody construct |
11/17/1998 | US5837815 Amino acid sequences with phosphorylation activity |
11/17/1998 | US5837814 Drug delivery; medical diagnosis; separations; protein fusion products |
11/17/1998 | US5837811 Proteins active in lymphocyte-mediated cytotoxicity |
11/17/1998 | US5837810 Polypeptides of lipopolysaccharide binding protein |
11/17/1998 | US5837686 Polypeptides for antiarthritic agents |
11/17/1998 | US5837676 Use of scatter factor to enhance angiogenesis |
11/17/1998 | US5837541 Capable of protecting against bacterial infections |
11/17/1998 | US5837540 Method of producing fibrin-specific antibodies using soluble fibrin polymers as an immunogen |
11/17/1998 | US5837539 Monoclonal antibodies for human mesenchymal stem cells |
11/17/1998 | US5837538 Patched genes and their use |